Pharmacokinetics and relative bioavailability of arbidol hydrochloride tablets and capsules in Chinese healthy volunteers

Chinese Pharmaceutical Journal

Volumn 43, Issue 16, 2008, Pages

  Feng, Yu Fei ^a   Lü, Jun Ling ^a   Song, Li Jie ^b   Li, Ke Xin ^a   Sun, Chun Hua ^a  

^a Clinical Pharmacology Base of Beijing Hospital   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Arbidol; Capsule; HPLC; Pharmacokinetics; Relative bioavailability; Tablet

Indexed keywords

ARBIDOL;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NORMAL HUMAN;

EID: 53049088751     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. SHUMLOV V I, SHUSTER A M, LOBASTOV S P, et al. Efficacy of arbidol in prophylaxs and treatment of acute respiratory viral infectons in servicemen (Russian) [J]. Voen Med Zh,2002,323(9):51-53.
2. WANG M Z, CAI B Q, LI L Y, et al. Efficacy and safety of arbidol in treatment of naturally acquired influenza [J]. Acta Acad Med Sin,2004,26(3):289-293.
3. METZ R, MUTH P, FERGER M, et al. Sensitive high-performance liquid chromatographic determination of arbidol, a new antiviral compound, in human plasma [J]. J Chromatogr A,1998,810(1-2):63-69.